Bereiding en karakterisering van de individuele en multi-geneesmiddel beladen Fysiek Ingesloten Polymeer Micellen

The overall goal of the following experiment is to outline a step-by-step process of preparing and characterizing drug loaded my cells before evaluating them in disease states of interest. This is achieved by preparing the My cells by solvent casting method to generate reproducible my cells for the study. As a second step, my cell loading stability and size are assessed, which determines the ability of the my cells to load and retain clinically relevant concentrations.

Next, the rate of drug release from the My cells is determined in order to ensure my cells have appropriate in vitro release characteristics before assessing in vivo stability. The results show that reproducibly generated stable my cells can provide a platform to pursue drug delivery in various disease states based on the assessment techniques presented here. The main advantage of this technique or existing methods like equilibrium loading or dialysis methods, is that the myosins can be prepared much faster with reproducible drug loading and size.

The implications of this technique extend toward therapy or diagnosis of various disease states because nanoscale medicines offer opportunities beyond conventional forms, Generally individuals who are just beginning might struggle with these techniques even though they're simple because still you get to do the release studies, you can't really evaluate the burst effect. Demonstrating these procedure will be Shaman Duke, my graduate student, and Deepa my collaborator First weigh out one milligram of DTX, one milligram of EVR and 15 milligrams of Peg 4, 000 block PLA 2200 for the dual drug my cells or DDM. After weighing out, dissolve the drugs and the polymer in 0.5 milliliters of aceto nitrile, then transfer the solution to a five milliliter round bottom flask form a thin drug distributed polymer film by evaporating the drug polymer aceto solution under reduced pressure using a rotary evaporator.

Following this rehydrate the drug polymer film with 0.5 milliliters of deionized water preheated at 50 degrees Celsius and gently shake the flask in a 50 degrees Celsius water bath to form the mice cells. Add the solution to a centrifuge tube and spin at 7, 200 times G for three minutes. Draw up the solution with a needle and filter the resulting Micella solution into a new 1.5 milliliter centrifuge tube using a 0.2 micron nylon filter to remove any unsolved drug or contaminants At this point, perform reverse-phase HPLC analysis with a C eight column equilibrated at 40 degrees Celsius in an is Socratic mode with a mobile phase of acetyl I trial and water dilute the freshly prepared mycells in ace eye trial at a one to 100 ratio prior to analyzing by reverse phase HPLC to determine the initial drug loading.

After storing undiluted my cells at room temperature for 48 hours, prepare fresh diluted samples to reassess by reverse phase HPLC and determine the drug stability in my cells over 48 hours. Monitor the DTX and DVR peaks at 227 and 279 nanometers with retention times of 1.7 and 5.7 minutes Respectively. Present the data as the mean plus or minus standard deviation of the drug loading.

Next, dilute the freshly prepared my cells and deionized water at a one to 20 ratio te a final polymer concentration of 1.5 milligrams per milliliter. Transfer the solution to a vet for dynamic light scattering measurement. Measure the intensity of helium neon laser at 173 degrees to determine the scattering.

Present the data as the mean Z average size plus or minus standard deviation along with the poly dispersity index or PDI of the distribution. After preparing DDM as previously described, load 2.5 milliliters of the my cells into a three milliliter dialysis cassette with a molecular weight cutoff of 7, 000 grams per mole. Place the cassette in 2.5 liters of 10 millimolar pH 7.4 phosphate buffer during the following intervals.

Withdraw 150 microliters of the solution and replace with 150 microliters of fresh buffer. Change the buffer every three hours to ensure sync conditions. Analyze the samples using reverse phase HPLC to determine the drug concentration curve.

Fit the drug release data based on a simple diffusion model with a one phase exponential association using statistical software D-T-X-E-V-R and the DDM showed similar stability in PEG 2000 block PLA 1800 or PEG 2000 block PLA 2200 over 48 hours. All the, my cells retained 97%or more of the initial loading at 48 hours at room temperature. Based on the dynamic light scattering results, all my cells showed a unimodal distribution with PDI values of less than 0.2.

Based on the data DTX release from individual mycells and DDM was approximately 60%over 48 hours. EVR release from individual my cells and DDM was 60%and 50%respectively. The time needed for 50%drug release from individual my cells and DDM and the goodness of fit data are presented here.

The goodness of curve fitting for all my cells except EVR individual, my cells is above 0.950, which means that the assumption of first order release is a good approximation to explain drug release from individual my cells and DDM Once mastered, these techniques can be done routinely on a library of drugs and polymers as my cells in a matter of hours to week. While attending this procedure, it's important to remember to completely characterize the my cells before accessing the cell culture or the animal models following These procedures. Other delivery system like liposomal delivery system can also be evaluated or characterized in order to answer the the question about the role of drug delivery system in the efficacy of treatment.

After watching this video, you should have a good understanding of how to prepare and characterize drug loading my cells before evaluating them in disease. State of interest.